Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Short-term Investments (2016 - 2023)

Ironwood Pharmaceuticals (IRWD) has disclosed Short-term Investments for 14 consecutive years, with $788000.0 as the latest value for Q3 2023.

  • Quarterly Short-term Investments fell 36.96% to $788000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $788000.0 through Sep 2023, down 36.96% year-over-year, with the annual reading at $1.3 million for FY2022, 4.0% up from the prior year.
  • Short-term Investments hit $788000.0 in Q3 2023 for Ironwood Pharmaceuticals, roughly flat from $788000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $7.7 million in Q2 2019 to a low of $788000.0 in Q2 2023.
  • Historically, Short-term Investments has averaged $2.0 million across 5 years, with a median of $1.2 million in 2019.
  • Biggest five-year swings in Short-term Investments: crashed 97.48% in 2019 and later soared 38.8% in 2020.
  • Year by year, Short-term Investments stood at $1.2 million in 2019, then soared by 38.8% to $1.7 million in 2020, then decreased by 27.95% to $1.2 million in 2021, then increased by 4.0% to $1.3 million in 2022, then tumbled by 39.38% to $788000.0 in 2023.
  • Business Quant data shows Short-term Investments for IRWD at $788000.0 in Q3 2023, $788000.0 in Q2 2023, and $1.2 million in Q1 2023.